BRISTOL, Tenn., Aug. 2 /PRNewswire-FirstCall/ -- King Pharmaceuticals,
Inc. (NYSE: KG) reported today that the Company will provide a live webcast of
its conference call to be held following King's announcement of earnings for
the second quarter ending June 30, 2004. As previously announced, King plans
to announce earnings for the second quarter ending June 30, 2004, prior to the
market open on Thursday, August 5, 2004.
Interested persons may listen to the conference call on Thursday, August
5, 2004, at 1:00 p.m., E.D.T.
at http://phx.corporate-ir.net/playerlink.zhtml?c=93939&s=wm&e=918761 or by
dialing 800-905-0392 (US only) or 785-832-2422 (international), passcode KG.
If you are unable to participate during the live webcast, the call will be
archived on King's web site http://www.kingpharm.com for not less than 30 days
following the call. A replay of the conference call will also be available
for not less than 30 days following the call by dialing 888-274-8337 (US only)
or 402-220-2329 (international).
(Minimum requirements to listen to the broadcast: The Windows Media Player
software, downloadable free
from http://www.microsoft.com/windows/windowsmedia/EN/default.asp, and at
least a 28.8 kbps connection to the internet.)
About King Pharmaceuticals
King, headquartered in Bristol, Tennessee, is a vertically integrated
branded pharmaceutical company. King, an S&P 500 Index company, seeks to
capitalize on opportunities in the pharmaceutical industry through the
development, including through in-licensing arrangements and acquisitions, of
novel branded prescription pharmaceutical products in attractive markets and
the strategic acquisition of branded products that can benefit from focused
promotion and marketing and product life-cycle management.
This release contains forward-looking statements which reflect
management's current views of future events and operations, including, but not
limited to, statements pertaining to the anticipated date for release of the
Company's financial results for the second quarter ending June 30, 2004 and
the live webcast of the conference call following the release. These forward-
looking statements involve certain significant risks and uncertainties, and
actual results may differ materially from the forward-looking statements.
Some important factors which may cause results to differ include: dependence
on King's ability to release the Company's financial results for second
quarter ending June 30, 2004, and conduct its conference call as currently
planned on August 5, 2004. Other important factors that may cause actual
results to differ materially from the forward-looking statements are discussed
in the "Risk Factors" section and other sections of King's Form 10-K for the
year ended December 31, 2003 and Form 10-Q for the first quarter ended March
31, 2004 which are on file with the Securities and Exchange Commission. King
does not undertake to publicly update or revise any of its forward-looking
statements even if experience or future changes show that the indicated
results or events will not be realized.
SOURCE King Pharmaceuticals, Inc.
 back to top
Related links:
http://www.kingpharm.com
http://phx.corporate-ir.net/playerlink.zhtml?c=93939&s=wm&e=918761
Company News On-Call:
http://www.prnewswire.com/comp/120319.html
CONTACT:
James E. Green, Executive Vice President,
Corporate Affairs of King Pharmaceuticals, Inc., +1-423-989-8125
|
